False negative RT-PCR or false positive serological testing in SARS-CoV-2 diagnostics? Navigating between Scylla and Charybdis to prevent misclassification bias in COVID-19 clinical investigations

[1]  Kendall W. Cradic,et al.  Clinical Evaluation and Utilization of Multiple Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2 , 2020, American journal of clinical pathology.

[2]  M. Plebani,et al.  Diagnostic performances and thresholds: The key to harmonization in serological SARS-CoV-2 assays? , 2020, Clinica Chimica Acta.

[3]  H. Jarva,et al.  Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation , 2020, Journal of Clinical Virology.

[4]  C. Bethel,et al.  Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies , 2020, bioRxiv.

[5]  O. Vapalahti,et al.  Evaluation of commercial and automated SARS-CoV-2 IgG and IgA ELISAs using coronavirus disease (COVID-19) patient samples , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[6]  E. Göttgens,et al.  Rapid identification of SARS-CoV-2-infected patients at the emergency department using routine testing , 2020, medRxiv.

[7]  G. Lippi,et al.  Assessment of immune response to SARS-CoV-2 with fully automated MAGLUMI 2019-nCoV IgG and IgM chemiluminescence immunoassays , 2020, Clinical chemistry and laboratory medicine.

[8]  Victor M. Montori,et al.  COVID-19 Testing , 2020, Mayo Clinic Proceedings.

[9]  Giuseppe Lippi,et al.  Coronavirus disease 2019 (COVID-19): the portrait of a perfect storm , 2020, Annals of translational medicine.

[10]  Mario Plebani,et al.  Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19) , 2020, Clinical chemistry and laboratory medicine.